These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 19732196)
1. Treating allergy: where to from here? O'Hehir RE Intern Med J; 2009 Aug; 39(8):491-4. PubMed ID: 19732196 [No Abstract] [Full Text] [Related]
2. Shooting for a faster approach to the immunotherapy target: will cluster become conventional? Cox LS Ann Allergy Asthma Immunol; 2009 Mar; 102(3):177-8. PubMed ID: 19354062 [No Abstract] [Full Text] [Related]
3. Future of allergen-specific immunotherapy: better understanding of the mechanisms, novel treatments, and long-term cure. Akdis CA Immunol Allergy Clin North Am; 2006 May; 26(2):xiii-xxii. PubMed ID: 16701138 [No Abstract] [Full Text] [Related]
5. Editorial: Novel Advances in Allergy Diagnosis and Treatment. Blank S; Hilger C Front Immunol; 2021; 12():662699. PubMed ID: 33927726 [No Abstract] [Full Text] [Related]
6. [Recombinant allergens; allergy vaccine in the future?. Interview by Dr. Barbara Scholtissek]. Valenta R Wien Med Wochenschr; 1999; 149(14-15):450-1. PubMed ID: 10584293 [No Abstract] [Full Text] [Related]
7. Allergy Immunotherapy: Are We Making Progress or Just Standing Still? Cox LS Immunol Allergy Clin North Am; 2020 Feb; 40(1):xiii-xiv. PubMed ID: 31761125 [No Abstract] [Full Text] [Related]
8. How to stop the allergy march. Lopes Dos Santos JM Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):39-40. PubMed ID: 17761107 [No Abstract] [Full Text] [Related]
9. Allergen-specific immunotherapy: current concepts and future directions. Bieber T; Simon HU Allergy; 2011 Jun; 66(6):709-12. PubMed ID: 21518373 [No Abstract] [Full Text] [Related]
10. The impact of molecular biology on allergen immunotherapy. Bush RK Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):557-8. PubMed ID: 21030836 [No Abstract] [Full Text] [Related]
11. What should drive the choice of allergen for immunotherapy in polysensitized patients? Ciprandi G; Incorvaia C; Puccinelli P; Dell'Albani I; Frati F Ann Allergy Asthma Immunol; 2012 Aug; 109(2):148-9. PubMed ID: 22840259 [No Abstract] [Full Text] [Related]
13. [Immunological mechanisms in allergen-specific immunotherapy: impact on future trends in type-1 allergy management]. Ebner C Wien Med Wochenschr; 1999; 149(14-15):438-41. PubMed ID: 10584289 [TBL] [Abstract][Full Text] [Related]
14. Allergen vaccines for specific diagnosis. Larsen JN; Løwenstein H Clin Allergy Immunol; 2000; 15():1-51. PubMed ID: 10943287 [No Abstract] [Full Text] [Related]
17. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy. Crameri R Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139 [TBL] [Abstract][Full Text] [Related]
18. [Trends of international research work on immune toxicology and occupational allergy]. Kusaka Y Sangyo Igaku; 1992 Dec; 34(7):663-6. PubMed ID: 1300386 [No Abstract] [Full Text] [Related]
19. LAIS - Posological schedules. Bruno M Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):33-4. PubMed ID: 17761105 [No Abstract] [Full Text] [Related]
20. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy. Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D J Allergy Clin Immunol; 2009 Aug; 124(2):385; author reply 385-6. PubMed ID: 19482349 [No Abstract] [Full Text] [Related] [Next] [New Search]